The evidence-based treatment of AIDS-related Non-Hodgkin's lymphoma

Cancer Treatment Reviews

Volumn 30, Issue 3, 2004, Pages 249-253

  Stebbing, Justin ^a   Marvin, Vanessa ^b   Bower, Mark ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

Author keywords

AIDS; Chemotherapy; HIV; Lymphoma; Non Hogdkin's lymphoma; Primary cerebral lymphoma

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; BLEOMYCIN; CISPLATIN; COLONY STIMULATING FACTOR; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; PROTEINASE INHIBITOR; RITUXIMAB; SAQUINAVIR; VINCRISTINE; VINDESINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW TOXICITY; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; DOSE RESPONSE; DRUG MEGADOSE; DRUG TOLERABILITY; EPIDEMIC; EVIDENCE BASED MEDICINE; HEMATOLOGIC DISEASE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE DEFICIENCY; MUCOSA INFLAMMATION; NEUROLOGIC DISEASE; NEUTROPENIA; NONHODGKIN LYMPHOMA; OPPORTUNISTIC INFECTION; PROGNOSIS; REVIEW; SEPSIS;

EID: 1842690776     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctrv.2003.12.004     Document Type: Article

References (32)

1. Dal Maso L, Franceschi S. Epidemiology of non-Hodgkin lymphomas and other haemolymphopoietic neoplasms in people with AIDS. Lancet Oncol 2003;4(2):110-9.
2. International collaboration on HIV and Cancer. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 2000;92(22):1823-30.
3. Fong IW, Ho J, Toy C, Lo B, Fong MW. Value of long-term administration of acyclovir and similar agents for protecting against AIDS-related lymphoma: case-control and historical cohort studies. Clin Infect Dis 2000;30:757-61.
4. Matthews G, Bower M, Mandalia S, Powles T, Nelson M, Gazzard B. Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active antiretroviral therapy. Blood 2000;96:2730-4.
5. Grulich AE, Wan X, Law MG, Milliken ST, Lewis CR, Garsia RJ, et al. B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS. AIDS 2000;14:133-40.
6. Kaplan LD, Abrams DI, Feigal E, McGrath M, Kahn J, Neville P, et al. AIDS-associated non-Hodgkin's lymphoma in San Francisco. J Am Med Assoc 1989;261(5):719-24.
7. Levine AM, Sullivan Halley J, Pike MC, Rarick MU, Loureiro C, Bernstein Singer M, et al. Human immunodeficiency virus-related lymphoma. Prognostic factors predictive of survival. Cancer 1991;68(11):2466-72.
8. Rossi G, Donisi A, Casari S, Re A, Cadeo G-P, Carosi G. The International Prognostic Index can be used as a guide to treatment decisions regarding patients with human immunodeficiency virus-related non-Hodgkin lymphoma. Cancer 1999;86:2391-7.
9. Straus DJ, Huang J, Testa MA, Levine AM, Kaplan LD. Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142-low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor. J Clin Oncol 1998;16:3601-6.
10. Kaplan LD, Straus DJ, Testa MA, Von Roenn J, Dezube BJ, Cooley TP, et al. Low dose compared with standard dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. N Engl J Med 1997;336:1641-8.
11. Tirelli U. Dose adjusted treatment in AIDS-related lymphoma. J Acq Immunodef Synd 2000;23:A12.
12. Navarro JT, Ribera JM, Oriol A, Vaquero M, Romeu J, Battle M, et al. Influence of highly active anti-retrovirat therapy on response to treatment and survival in patients with acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma treated with cyclophosphamide, hydroxydoxorubicin, vincristine and prednisone. Br J Haematol 2001;112(4):909-15.
13. Vaccher E, Spina M, di Gennaro G, Talamini R, Nasti G, Schioppa O, et al. Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma. Cancer 2001;91(1):155-63.
14. Sparano JA, Wiernik PH, Strack M, et al. Infusional cyclophosphamide, doxorubicin and etoposide in HIV and HTLV-1 related non Hodgkin's lymphoma. Blood 1993;81:2810-5.
15. Sparano JA, Wiernik PH, Hu X, Sarta C, Schwartz EL, Soeiro R, et al. Pilot trial of infusional cyclophosphamide, doxorubicin and etoposide plus didanosine and filgrastim in patients with HIV associated non-Hodgkin's lymphoma. J Clin Oncol 1996;14:3026-35.
16. Sparano JA, Wiernik PH, Hu X, Sarta H, Henry DH, Ratech H. Saquinavir enhances the mucosal toxicity of infusional cyclophosphamide, doxorubicin and etoposide in patients with HIV-associated non-Hodgkin's lymphoma. Med Oncol 1998;15:50-7.
17. Sparano JA, Weller E, Nazeer T, Habermann T, Traynor AE, Manalo J, et al. Phase 2 trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with poor-prognosis, intermediate-grade non-Hodgkin lymphoma: an Eastern Cooperative Oncology Group trial (E3493). Blood 2002;100(5):1634-40.
18. Little RF, Pearson D, Steinberg S, Elwood PE, Yarchoan R, Wilson WH. Dose-adjusted EPOCH chemotherapy in previously untreated HIV-associated non-Hodgkin's lymphoma. Proc Am Soc Clin Oncol 1999;18:10a.
19. Little RF, Pittaluga S, Grant N, Steinberg SM, Kavlick MF, Mitsuya H, et al. Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology. Blood 2003.
20. Tirelli U, Spina M, Jaeger U, Nigra E, Blanc PL, Liberati AM, et al. Infusional CDE with rituximab for the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: preliminary results of a phase I/II study. Recent Results Cancer Res 2002;159:149-53.
21. Boue F, Gabarre J, Gisselbrecht C, Reynes J, Plantier I, Morlat P, et al. CHOP chemotherapy plus Rituximab in HIV patients with high grade lymphoma - results of an ANRS Trial. Proc ASH 2003 [Abst 1824].
22. Kaplan LD, Scadden DT, for the AIDS malignancies consortium. No benefit from rituximab in a randomized phase III trial of CHOP with or without rituximiab for patients with HIV-associated non-Hodgkin's lymphoma: AIDS malignancies consortium study 010. Proc Am Soc Clin Oncol 2003;22:564 [Abstract].
23. Levine AM, Espina BM, Yuzon R, Sanchez MN, Dharmapala D, Gill PS, et al. Treatment of relapsed/refractory AIDS related lymphomas with high dose cytarabine/cisplatin combination regimens. J Acq Immunodef Synd 2000;23:A24.
24. Kentos A, Vekemans M, Van Vooren JP, Lambermont M, Liesnard C, Feremans W, et al. High-dose chemotherapy and autologous CD34-positive blood stem cell transplantation for multiple myeloma in an HIV carrier. Bone Marrow Transplant 2002;29(3):273-5.
25. Krishnan A, Molina A, Zaia J, Nademanee A, Kogut N, Rosenthal J, et al. Autologous stem cell transplantation for HIV-associated lymphoma. Blood 2001;98(13):3857-9.
26. Molina A, Krishnan AY, Nademanee A, Zabner R, Sniecinski I, Zaia J, et al. High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy. Cancer 2000;89(3):680-9.
27. Gabarre J, Azar N, Autran B, Katlama C, Leblond V. High-dose therapy and autologous haematopoietic stem-cell transplantation for HIV-1-associated lymphoma. Lancet 2000;355(9209):1071-2.
28. Campbell P, Iland H, Gibson J, Joshua D. Syngeneic stem cell transplantation for HIV-related lymphoma. Br J Haematol 1999;105(3):795-8.
29. Gabarre J, Leblond V, Sutton L, Azar N, Jouan M, Boccaccio C, et al. Autologous bone marrow transplantation in relapsed HIV-related non-Hodgkin's lymphoma. Bone Marrow Transplant 1996;18(6):1195-7.
30. Bower M, Fife K, Sullivan A, Kirk S, Phillips RH, Nelson M, et al. Treatment outcome in presumed and confirmed AIDS-related primary cerebral lymphoma. Eur J Cancer 1999;35(4):601-4.
31. Baumagartner JE, Rachlin JR, Beckstead JH, Meeker TC, Levy R, Wara WM, et al. Primary central nervous system lymphomas: natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome. J Neurosurg 1990;73(2):206-11.
32. Jacomet C, Girard PM, Lebrette MG, Farese VL, Monfort L, Rozenbaum W. Intravenous methotrexate for primary central nervous system non-Hodgkin's lymphoma in AIDS. AIDS 1997;11:1725-30.